Jiangxi Fushine Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 821.16 million compared to CNY 740.09 million a year ago. Revenue was CNY 831.15 million compared to CNY 775.85 million a year ago.

Net income was CNY 45.31 million compared to CNY 152.37 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.28 a year ago. Diluted earnings per share from continuing operations was CNY 0.08 compared to CNY 0.28 a year ago.